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Background
CD4 T-lymphocytes play a prominent role in Type 1 DM.
The NOD mouse is a model for this autoimmune disease.
The earliest histological signs of autoimmunity in female
NOD mice occur at approximately 5 weeks of age. We
hypothesized that this process may be preceded by molec-
ular events in the CD4 T-lymphocytes. To test this hypoth-
esis, we analyzed the transcriptomes of CD4 T-
lymphocytes of young "prepathologic" NOD mice.
Methods
Using a magnetic separation system (Miltenyi Biotec), we
isolated CD4 T-lymphocytes from spleen leukocytes of
female NOD mice, and two control strains, NOR and
C57Bl/6, at 2, 3, and 4 weeks of age (n = 5 for each strain,
except for NOD 2 wk where n = 4). CD4 T-lymphocyte
transcriptomes were characterized on Affymetrix Mouse
430_2 expression arrays probing ~39,000 mouse genes/
ESTs. Gene lists produced from statistical analyses were
mined using Ingenuity Pathway Analysis http://
www.ingenuity.com.
Results
Analysis by 1-way ANOVA (p < 0.005, Benjamin-Hoch-
berg Multiple Test Correction (MTC) defined 311, 624,
and 581 probesets (genes) with highly significant expres-
sion differences between strains at 2, 3 and 4 weeks,
respectively. Hierarchical clustering of these probeset lists
identified 58, 115, and 65 probesets, respectively for 2, 3,
and 4 week old mice, as being differentially expressed in
NOD mice relative to both control strains (17, 32, and 9
were upregulated in NOD mice while 41, 83, and 56 were
downregulated). Pathway analysis of the 3 gene lists (58,
115 and 64 probesets) revealed that 7 (HNF4A, IFNG, IL4,
TP53, BCL2L1, IL15, and prostaglandin E2) of the top 15
central genes in each network were common to all age
groups. IL6 was central in networks of 2 and 4 week old
mice but not of 3 week old mice. Uniquely central to indi-
vidual networks were: MYC, JUN and HRAS at 2 weeks;
TNF, NFKB, p38MAPK, and TGFB1 at 3 weeks; and Inter-
feron alpha, IL12 and STAT4 at 4 weeks.
Conclusion
We conclude that young, prediabetic NOD mice have
basic (i.e. common, most likely genetic) molecular defects
in CD4 T-cells associated with apoptosis/cellular prolifer-
ation, Th1-Th2 differentiation and cytokine signaling.
Furthermore, abnormalities in apoptosis/cellular prolifer-
ation predominate at 2 weeks of age while those in cellu-
lar activation/acute phase response signaling and
inflammation predominate in 3 week old mice. Finally,
abnormalities in the innate immune response and its link
to the adaptive immune response are evident at 4 weeks of
age.
from UT-ORNL-KBRIN Bioinformatics Summit 2009
Pikeville, TN, USA. 20–22 March 2009
Published: 25 June 2009
BMC Bioinformatics 2009, 10(Suppl 7):A15 doi:10.1186/1471-2105-10-S7-A15
<supplement> <title> <p>UT-ORNL-KBRIN Bioinformatics Summit 2009</p> </title> <editor>Eric C Rouchka and Julia Krushkal</editor> <note>Meeting abstracts – A single PDF containing all abstracts in this Supplement is available <a href="http://www.biomedcentral.com/content/pdf/1471-2105-10-S7-full.pdf">here</a>.</note> <url>http://www.biomedcentral.com/content/pdf/1471-2105-10-S7-info.pdf</url> </supplement>
This abstract is available from: http://www.biomedcentral.com/1471-2105/10/S7/A15
© 2009 Kakoola et al; licensee BioMed Central Ltd. Publish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
BMC Bioinformatics 2009, 10(Suppl 7):A15 http://www.biomedcentral.com/1471-2105/10/S7/A15
Page 2 of 2
(page number not for citation purposes)
Acknowledgements
This work was supported by a research supplement grant from the 
National Institute of Diabetes & Digestive & Kidney Diseases, DK062103.